Yes, Crohn's disease is a recognized cause of bronchiectasis
Patients with inflammatory bowel disease, including Crohn's disease, should be investigated for bronchiectasis when they present with chronic productive cough or recurrent chest infections. 1
The Association is Well-Established
The British Thoracic Society guidelines explicitly recommend considering investigation for bronchiectasis in patients with inflammatory bowel disease (which includes Crohn's disease) who have chronic productive cough 1. This recommendation reflects the recognized association between these conditions, though the exact causal mechanism remains incompletely understood.
Prevalence and Clinical Significance
The prevalence of bronchiectasis in IBD patients is substantial:
- Overall prevalence: 5% among all IBD patients 2
- When using high-resolution CT (HRCT): 12% 2
- In one large cohort: 34.5% of IBD patients showed bronchiectasis on chest HRCT 3
This suggests bronchiectasis may be an underestimated extraintestinal manifestation of Crohn's disease 2.
Key Clinical Characteristics
When bronchiectasis occurs in Crohn's disease patients, it typically presents with:
- Multiple lobe involvement (72% have ≥2 lobes affected) 3
- Central predominance in distribution 3
- Cylindrical type (>90% of cases) 3
- Mild severity in most cases 3
- Often asymptomatic - many patients have no respiratory symptoms despite radiographic findings 3
The most frequent pulmonary manifestation is bronchial inflammation and suppuration with or without bronchiectasis 4.
Risk Factors to Monitor
Independent risk factors for developing bronchiectasis in IBD patients include:
- Age of IBD onset ≥35 years (OR 2.05) 3
- History of immunosuppressant therapy (OR 3.93) 3
- ESR >20 mm/h (OR 2.01) 3
- Positive ASCA antibodies (OR 1.37) 3
Important Caveats
The relationship is not genetically predetermined. A 2024 Mendelian randomization study found no genetic causal relationship between IBD/Crohn's disease and bronchiectasis 5. This means the association is likely due to shared inflammatory pathways, immunosuppressive treatments, or other acquired factors rather than genetic predisposition.
Temporal relationship varies. In most patients, pulmonary disease develops parallel to intestinal disease activity 4, though the pulmonary findings are not necessarily associated with bowel disease activity 6.
Clinical Approach
For Crohn's disease patients with respiratory symptoms (chronic productive cough, recurrent chest infections):
- Obtain chest X-ray initially 1
- Confirm with thin-section CT scan 1
- Consider HRCT even in asymptomatic patients with risk factors, as subclinical presentations are common 3, 2
Treatment is typically steroid-responsive 4, 6, with most patients requiring corticosteroids in initial management. Resolution of pulmonary lesions often parallels improvement in intestinal symptoms 6.
The high prevalence (particularly when actively screened with HRCT) and potential for serious complications like airway stenosis or bronchiolitis obliterans if untreated 7 make this an important extraintestinal manifestation to recognize and monitor in Crohn's disease patients.